» Articles » PMID: 17574599

Awareness of Stroke Risk in Chagasic Stroke Patients

Overview
Journal J Neurol Sci
Publisher Elsevier
Specialty Neurology
Date 2007 Jun 19
PMID 17574599
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Reduction in stroke risk may depend on the general population's knowledge of stroke. In South America, chagasic myocardiopathy is independently associated with ischemic stroke.

Objective: The aim of this study was to evaluate awareness of Chagas' disease (CD) as a stroke risk factor and to determine the frequency of stroke patients that are diagnosed as having CD after stroke.

Methods: Eighty CD stroke patients and 140 non-chagasic stroke patients (53.2% males; mean age 60 years), consecutively admitted to the hospital during 2005 were interviewed with a questionnaire. Demographic variables included age, sex, ethnicity, education, previous history of stroke, vascular risk factors, social background information and several questions regarding awareness of CD as a stroke risk factor. A logistic regression model was developed to identify social variables that could predict the risk of CD stroke.

Results: The diagnosis of CD was established after stroke in 42.5% of CD stroke patients. Most respondents (95%) were not aware of stroke risk in CD. Chagasic patients had the lowest rate of awareness about stroke risk (2.5 vs 7.1%), although they had the greatest knowledge about the kissing bug vector (83.7 vs 62.1%; p<0.001). The main social variables associated with CD stroke were: having family members with Chagas' disease (p<0.0001; odds ratio 10.1; 95% CI 3.6-16.1) and a past history of living in a mud-brick house during childhood (p<0.001; odds ratio 8.9; 95% CI: 4.1-24.6).

Conclusion: Awareness about CD as a risk factor of stroke is low. Educational campaigns about risk of stroke in CD patients are encouraged.

Citing Articles

Chagas disease as an underrecognized cause of stroke: implications for public health.

Vasconez-Gonzalez J, Mino C, Salazar-Santoliva C, Villavicencio-Gomezjurado M, Ortiz-Prado E Front Med (Lausanne). 2024; 11:1473425.

PMID: 39650191 PMC: 11621944. DOI: 10.3389/fmed.2024.1473425.


Unveiling Lovastatin's Anti-Inflammatory Potential in Mouse's Brain during Acute Infection.

Gonzaga B, Nisimura L, Coelho L, Rodrigues Ferreira R, Horita S, Beghini D Biology (Basel). 2024; 13(5).

PMID: 38785783 PMC: 11118176. DOI: 10.3390/biology13050301.


Stroke in central nervous system infections.

Carod-Artal F Ann Indian Acad Neurol. 2022; 11(Suppl 1):S64-S78.

PMID: 35721447 PMC: 9204120.


Healthcare Professionals and Students' Awareness of Chagas Disease: Design and Validation of Chagas Level of Knowledge Scale (ChaLKS).

Ramos-Rincon J, Mira-Solves J, Ramos-Sesma V, Torrus-Tendero D, Llenas-Garcia J, Navarro M Am J Trop Med Hyg. 2020; 103(1):437-444.

PMID: 32342845 PMC: 7356480. DOI: 10.4269/ajtmh.19-0677.


Epidemiology of Chagas disease in Europe: many calculations, little knowledge.

Strasen J, Williams T, Ertl G, Zoller T, Stich A, Ritter O Clin Res Cardiol. 2013; 103(1):1-10.

PMID: 23989652 DOI: 10.1007/s00392-013-0613-y.